Your browser doesn't support javascript.
loading
Obinutuzumab Versus Rituximab Immunochemotherapy in Previously Untreated iNHL: Final Results From the GALLIUM Study.
Townsend, William; Hiddemann, Wolfgang; Buske, Christian; Cartron, Guillaume; Cunningham, David; Dyer, Martin J S; Gribben, John G; Phillips, Elizabeth H; Dreyling, Martin; Seymour, John F; Grigg, Andrew; Trotman, Judith; Lin, Tong-Yu; Hong, Xiao-Nan; Kingbiel, Dirk; Nielsen, Tina G; Knapp, Andrea; Herold, Michael; Marcus, Robert.
Afiliação
  • Townsend W; Cancer Research UK and UCL Cancer Trials Centre, University College Hospitals London, United Kingdom.
  • Hiddemann W; Ludwig-Maximilians-University Hospital Munich, Germany.
  • Buske C; Universitätsklinikum Ulm, Germany.
  • Cartron G; CHU Montpellier, UMR CNRS 5535, Montpellier, France.
  • Cunningham D; Royal Marsden Hospital, Sutton, United Kingdom.
  • Dyer MJS; Ernest and Helen Scott Hematological Research Institute, University of Leicester, United Kingdom.
  • Gribben JG; Queen Mary, University of London, St Bartholomew's Hospital, London, United Kingdom.
  • Phillips EH; University of Manchester, The Christie Hospital and National Institutes of Health Research Manchester Biomedical Research Centre, Manchester, United Kingdom.
  • Dreyling M; Ludwig-Maximilians-University Hospital Munich, Germany.
  • Seymour JF; Peter MacCallum Cancer Centre, the Royal Melbourne Hospital, and University of Melbourne, VIC, Australia.
  • Grigg A; Austin Hospital, Heidelberg, VIC, Australia.
  • Trotman J; Concord Repatriation General Hospital, University of Sydney, Concord, NSW, Australia.
  • Lin TY; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, and Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Hong XN; Fudan University Shanghai Cancer Center, Shanghai, China.
  • Kingbiel D; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Nielsen TG; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Knapp A; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Herold M; HELIOS-Klinikum Erfurt, Germany.
  • Marcus R; Kings College Hospital, London, United Kingdom.
Hemasphere ; 7(7): e919, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37404773

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2023 Tipo de documento: Article